Review
Copyright ©The Author(s) 2022.
World J Gastrointest Surg. Nov 27, 2022; 14(11): 1179-1197
Published online Nov 27, 2022. doi: 10.4240/wjgs.v14.i11.1179
Table 1 Summary of various scoring systems which has been developed and/or validated for use in acute pancreatitis
Name
Components
Interpretation
Advantages
Disadvantages
Ranson ScoreTotal of 11 variables to be usedPredicts severity of AP and mortality on admission and 48 h of admissionHigh prognostic accuracy (AUC 0.81) compared to APACHE II (AUC 0.80), BISAP (AUC 0.79) and CTSI (AUC 0.80) in prediction of AP severity[36]Low sensitivity (66%) when used before 48 h compared to APACHE II (84%), Glasgow score (78%), HAPS (71%)
On admission: (1) WBC > 16 × 109/L; (2) Age > 55 yr; (3) Glucose > 10 mmol/L (200 mg/dL); (4) AST > 250 IU/L; and (5) LDH > 350 IU/LSeverity of AP: < 3: Unlikely SAP; ≥ 3: Likely SAPHigh prognostic accuracy (AUC 0.87) in prediction of mortality, similar to CTSI (AUC 0.87), slightly worse compared to APACHE II (AUC 0.91)[36]Higher sensitivity than BISAP (54%)[38]
48-h compared to admission: (1) Hct drop > 10%; (2) BUN increase > 1.79 mmol/L (5 mg/dL); (3) Calcium < 2 mmol/L (8 mg/dL); (4) Arterial PaO2 < 60 mmHg; (5) Base deficit > 4 mg/dL; and (6) Fluid needs > 6 L within 48 hMortality risk: 0-3: 1%; 3-4: 15%; 5-6: 40%; ≥ 7: Nearly 100%
The Glasgow-Imrie score8 variables calculated at 48 h of admission: (1) PaO2 < 59.3 mmHg; (2) Age > 55 yr; (3) WBC > 15 × 109/L; (4) Calcium < 2 mmol/L (8 mg/dL); (5) BUN > 44.8 mg/dL (serum urea > 16 mmol/L); (6) LDH > 600 IU/L; (7) Albumin < 32 g/L (3.2 g/dL); and (8) Glucose > 10 mmol/L (180 mg/dL)Predicts risk of SAPHas decent sensitivity (78%) and specificity (82%) when used even within/before 48 hLimited prognostic accuracy (< 70%) and positive predictive value (70%)
Severity of AP: < 3: Unlikely SAP; ≥ 3: Likely SAPHigh NPV in prediction for mortality (range 86%-100%)[39]Unable to provide timely assessment as patients are scored only at 48 h (original design of scoring system)
Risk of SAP in original study: 0: 7%; 1: 6%; 2: 16%; 3: 20%; 4: 61%; 5: 55%; 6: 100%; 7: 0%; 8: 100%Low PPV for prediction of mortality (range 18%-66%)[39]
APACHE II List of 15 variables used1: (1) History of severe organ failure/immunocompromised state e.g. Heart failure Class IV, cirrhosis, chronic lung disease, dialysis-dependent: (2) Age; (3) Temperature; (4) Mean arterial pressure; (5) Heart rate; (6) Respiratory rate; (7) FiO2; (8) Glasgow coma scale; (9) pH; (10) Sodium; (11) Potassium; (12) Creatinine; (13) Acute renal failure; (14) Hct; and (15) WBC countOriginal use: Predicts mortality in ICU; Validated studies: Predicts severity and risk of mortality in APCan be used at any timepoint during the course of diseaseCumbersome to use in view of long list of variables required
Interpretation2[32]: (1) < 8: Low risk of SAP, low risk of mortality; and (2) ≥ 8: High risk of SAP, high risk of mortalityHas decent sensitivity (71%) and specificity (80%) for predicting SAP, and has high sensitivity (92%) with slightly lower specificity (79%) in predicting mortality[36]Low specificity compared to Ranson score at 48 h (62% vs 93%) at 48 h of admission[38]
CTSIConsists of 2 componentsPredicts severity of AP (Sum of Balthazar score and extent of pancreatic necrosis): 0-3: Mild AP; 4-6: Moderate AP; 7-10: SAPAcceptable sensitivity (81%) and specificity (82%) in prediction of SAP[36]While able to predict SAP, score did not correlate with subsequent development of organ failure and extra-pancreatic complications
Balthazar score (grading of pancreatitis): A (0): Normal pancreas; B (1): Enlargement of pancreas; C (2): Inflammatory changes in pancreas and peripancreatic fat; D (3): Ill-defined single peripancreatic fluid collection; and E (4): ≥ 2 poorly defined peripancreatic fluid collectionPatients with > 30% necrosis have similar morbidity and mortality (additional scoring for > 50% is not useful)[29]
Extent of pancreatic necrosis: None: 0; ≤ 30%: 2; > 30%-50%: 4; > 50%: 6Requires the use of CT, and ideal time for imaging is ≥ 72 h from onset of symptoms
Modified CTSI (MCTSI)Consists of 3 components:Predicts severity of AP: 0-2: Mild AP; 4-6: Moderate AP; 8-10: SAPEasier to calculate compared to CTSICT assessment of severity may not correlate with incidence of organ failure and risk of infection[30]
Pancreatic inflammation: 0: Normal pancreas; 2: Intrinsic pancreatic abnormalities with/without inflammatory changes in peripancreatic fat; 4: Pancreatic/peripancreatic fluid collection/peripancreatic fat necrosisHigher interobserver reliability compared to CTSIRequires the use of CT, and ideal time for imaging is ≥ 72 h from onset of symptoms
Pancreatic necrosis: 0: None; 2: ≤ 30%; 4: > 30%Comparable to CTSI in prognostic accuracy for severity of AP; MCTSI (AUC 0.83, sensitivity 88%, specificity 80%); CTSI (AUC 0.80, sensitivity 81%, specificity 82%)[30]
Extra-pancreatic complications: 2: ≥ 1 of pleural effusion, ascites, vascular complications, parenchymal complications and/or gastrointestinal involvement
BISAPList of 5 variables used: (1) BUN > 25 mg/dL; (2) Impaired mental status; (3) SIRS; (4) Age > 60 yr; and (5) Pleural effusionPredicts mortality in AP. Mortality risk in original study (within 24 h in patients without evidence of organ failure)[28]: 0: 0.1%; 1: 0.4%; 2: 1.6%; 3: 3.6%; 4: 7.4%; 5: 9.5%Easy to use scoring system which can be used within 24 h of admissionPotential underscoring of patients if done within 24 h as pleural effusion may be a late development
Varying cut-offs proposed for mortality[37]: ≥ 2: AUC 0.82, sensitivity 81%, specificity 70%; ≥ 3: AUC 0.87, sensitivity 56%, specificity 91%Low sensitivity in prediction of SAP
Varying cut-offs proposed for SAP risk: ≥ 2: AUC 0.88, sensitivity 63%, specificity 82%; ≥ 3: AUC 0.87, sensitivity 51%, specificity 91%Inferior to Ranson score in prediction of mortality[37]
HAPSList of 3 variables: (1) Absence of rebound tenderness/guarding; (2) Normal Hct (males: ≤ 43.0%, females ≤ 39.6%); and (3) Normal creatinine ≤ 176.8 μmol/L (2 mg/dL)Predicts risk of mild APEasy and quick to use scoring system to predict risk of mild AP to determine dispositionMay miss out cases which appear to be mild AP but progress to moderately severe or severe if patients present early
Interpretation: 0: Predicts no pancreatic necrosis, need for dialysis, mechanical ventilation, or fatal outcome (PPV 98%, NPV 18%, specificity 97%, sensitivity 28%)[33]; ≥ 1: Unable to exclude risk of aboveUnable to predict risk of SAP
SOFAList of 5 variables used1, within 24 h of admission (graded 0-4 for each variable): (1) Glasgow coma scale; (2) Mean arterial pressure, or need for vasoactive agents; (3) PaO2/FiO2; (4) Platelet count; and (5) Total bilirubinOriginal use: Predicts mortality in ICURelatively easy to use scoring system compared to APACHE II, Ranson score and Glasgow-Imrie scoreUnderperforms compared to Ranson score (NPV for SAP: 98.0%, NPV for ICU admission: 100%, NPV for mortality: 100%) and Glasgow-Imrie score (NPV for SAP: 95.4%, NPV for ICU admission: 99.3%, NPV for mortality: 99.5%) when scored at 48 h[35]
Validated studies[35,42]: Predicts risk of SAP, ICU admission and mortality in APHigh NPV which can screen out mild disease or need for ICU admission at onset within 24 h of admission
Cut-off score of ≥ 7 to predict SAP, ICU admission and mortality: (1) SAP: AUC 0.966, PPV: 84.6%, NPV: 89.1%, sensitivity: 13.6%, specificity: 99.7%; (2) ICU admission: AUC 0.943, PPV: 61.5%, NPV: 98.1%, sensitivity 40.0%, specificity: 99.2%; and (3) Mortality: AUC: 0.968, PPV: 46.2%, NPV: 99.1%, sensitivity: 50.0%, specificity: 98.9%